Floatz logo

PEGASPARGASE

Thrombocytopenia

SWOG Cancer Research Networkprotein_peptidePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Thrombocytopenia cohort.

Asset / SponsorPhaseRating
Recombinant Human Thrombopoietin
Sun Yat-sen University
Phase 4BBB
sb-497115-gr
Institute of Hematology & Blood Diseases Hospital, China
Phase 4BB
Romiplostim
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3BB
Avatrombopag
Second Affiliated Hospital of Guangzhou Medical University
Phase 4BB
FILGRASTIM
OHSU Knight Cancer Institute
Phase 2BB

View all 50 →

Same molecule, other indications

PEGASPARGASE is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
80 / 100
View asset →
Adult Acute Lymphocytic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →